Real-world oral glucocorticoid-sparing effect of benralizumab in severe asthma

被引:1
|
作者
Jackson, David [1 ,2 ]
Roxas, Cris [1 ]
Thompson, Louise [1 ]
Fernandes, Mariana [1 ]
Green, Linda [1 ]
Kavanagh, Joanne [1 ]
Nanzer-Kelly, Alexandra [1 ]
D'Ancona, Grainne [1 ]
Kent, Brian [1 ]
机构
[1] Guys & St Thomas NHS Trust, Guys Severe Asthma Ctr, London, England
[2] Kings Coll London, London, England
关键词
Asthma; Severe asthma; Exacerbation;
D O I
10.1183/13993003.congress-2019.PA2527
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA2527
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Clinical Effectiveness of Benralizumab Is Independent of Baseline FeNO in Severe Eosinophilic Asthma: A Retrospective Real-World Observation Study in Five UK Severe Asthma Centers
    Jackson, D. J.
    Burhan, H.
    Menzies-Gow, A.
    Pfeffer, P. E.
    Nanzer, A.
    Gil, E. Garcia
    Morris, T.
    Tran, T. N.
    Hirsch, I
    Dube, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [42] Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies
    Casale, Thomas B.
    Burnette, Autumn
    Bourdin, Arnaud
    Howarth, Peter
    Hahn, Beth
    Stach-Klysh, Alexandra
    Khurana, Sandhya
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [43] Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies
    Casale, Thomas B.
    Burnette, Autumn
    Bourdin, Arnaud
    Howarth, Peter
    Hahn, Beth
    Stach-Klysh, Alexandra
    Khurana, Sandhya
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [44] Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma
    Menzella, Francesco
    Marchi, Mariarita
    Caminati, Marco
    Romagnoli, Micaela
    Micheletto, Claudio
    Bonato, Matteo
    Idotta, Giuseppe
    Nizzetto, Manuele
    D'Alba, Giuseppina
    Cavenaghi, Massimiliano
    Bortoli, Michela
    Beghe, Bianca
    Pini, Laura
    Benoni, Roberto
    Casoni, Gianluca
    Muzzolon, Rodolfo
    Michieletto, Lucio
    Bosi, Annamaria
    Mastrototaro, Andrea
    Diamandi, Adela
    Nalin, Mara
    Senna, Gianenrico
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (01)
  • [45] Real-world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta-analysis
    Charles, David
    Shanley, Jemma
    Temple, Sasha-Nicole
    Rattu, Anna
    Khaleva, Ekaterina
    Roberts, Graham
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (05): : 616 - 627
  • [46] Benralizumab-induced asthma remission: evidence from the real-world imPROve study
    Lommatzsch, M.
    Korn, S.
    Grund, T.
    Emmanuel, B.
    Shavit, A.
    Plate, T.
    Saathoff, M.
    Watz, H.
    ALLERGOLOGIE, 2022, 45 (08) : 615 - 615
  • [47] A Belgian real-world study indicates rapid and sustained asthma symptom control with benralizumab
    Dupont, Lieven
    Pilette, Charles
    Deschampheleire, Maud
    Eger, Katrien
    Martinot, Jean-Benoit
    Leys, Mathias
    Himpe, Ulrike
    Peche, Rudy
    Lins, Muriel
    Delovinfosse, Solange
    Simonis, Helene
    Herreman, An
    Quataert, Charlotte
    Feys, Tom
    Louis, Renaud
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [48] Early response and remission with benralizumab in patients with severe asthma and chronic rhinosinusitis with nasal polyposis ( CRSwNP) in the prospective real-world imPROve Asthma study
    Korn, S.
    Watz, H.
    Emmanuel, B.
    Plate, T.
    Saathoff, M.
    Shavit, A.
    Grund, T.
    Lommatzsch, M.
    PNEUMOLOGIE, 2023, 77 : S76 - S76
  • [49] Real-World Effectiveness of Omalizumab for the Treatment of Severe Asthma
    Tadrous, Mina
    Fernandes, Kimberly
    Khuu, Wayne
    Lebovic, Gerald
    Stanbrook, Matthew
    Martins, Diana
    Paterson, J. Michael
    Mamdani, Muhammad M.
    Juurlink, David N.
    Gomes, Tara
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 515 - 516
  • [50] Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST) A real-world prospective interventional trial
    Masaki, Katsunori
    Suzukawa, Maho
    Sasano, Hitoshi
    Harada, Norihiro
    Miyazaki, Yasunari
    Katsura, Hideki
    Tagaya, Etsuko
    Terada, Junko
    Hojo, Masayuki
    Sugimoto, Naoya
    Nagase, Hiroyuki
    Kono, Yuta
    Hiranuma, Hisato
    Gon, Yasuhiro
    Takemura, Ryo
    Irie, Misato
    Nakamura, Reina
    Kabata, Hiroki
    Miyata, Jun
    Fukunaga, Koichi
    ALLERGOLOGY INTERNATIONAL, 2025, 74 (02) : 274 - 282